XML 23 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Detail) (USD $)
3 Months Ended 12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares available for grant 5,800,000    
Common stock par value (in Dollars per share) $ 0.0005   $ 0.0005
Stock-based compensation expense $ 13,752,000 $ 12,342,000  
Total share-based compensation cost not yet recognized 68,700,000    
Total share-based compensation cost not yet recognized, remaining weighted average service period 2 years 7 months 35 days    
Retirement eligible employees equity award
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense 7,700,000 7,100,000  
Stock appreciation rights (SARs)
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense 1,900,000 1,800,000  
Total share-based compensation cost not yet recognized, remaining weighted average service period 6 years 10 months 15 days    
Award vesting period 4 years    
Award expiry period from date of grant 7 years    
Total compensation cost not yet recognized, period for recognition 4 years    
Outstanding shares unvested 2,000,000 [1],[2]   1,600,000
Aggregate Intrinsic value of outstanding shares 57,000,000    
Aggregate intrinsic value of shares vested and exercisable 40,900,000    
Stock grants during period 400,000    
Weighted average remaining contractual terms 4 years 7 months 24 days [1],[2]   4 years 4 months 2 days
Restricted stock units (RSUs)
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense 11,700,000 10,400,000  
Award vesting period 4 years    
Outstanding shares unvested 1,500,000 [3],[4]   1,800,000
Stock grants during period 500,000 [5]    
Weighted average remaining contractual terms 1 year 9 months 12 days    
Restricted stock units (RSUs) | Executive officer
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock grants during period 200,000    
Restricted stock units (RSUs) | Non executive
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock grants during period 300,000    
Performance-based RSUs
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 4 years    
Common stock equivalents (CSEs)
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Outstanding shares unvested 102,935   102,479
Stock grants during period 2,253    
Base fee percentage 50.00%    
Target amount | Restricted stock units (RSUs) | Executive officer | Minimum
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of shares authorized for grant 0.00%    
Target amount | Restricted stock units (RSUs) | Executive officer | Maximum
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of shares authorized for grant 200.00%    
Unvested | Stock appreciation rights (SARs)
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Outstanding shares unvested 1,000,000    
Employee stock purchase plan
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Employee stock purchase plan, stock purchases as percentage of employee compensation maximum 10.00%    
Maximum share value authorized for purchase under employee stock purchase plan 23,750    
Exercisable price percentage of closing price of another class of stock 95.00%    
Maximum number of shares that may be purchased by eligible participants 1,200,000    
Proceeds from stock plans $ 2,400,000 $ 2,000,000  
[1] Total SARs outstanding had an intrinsic value of $57.0 million. SARs vested and exercisable had an intrinsic value of $40.9 million.
[2] As of March 31, 2014, 1.0 million of the SARs outstanding were unvested. The Company expects that substantially all of these unvested awards will vest in future periods.
[3] The weighted-average remaining contractual term of the outstanding RSUs is approximately 1.8 years.
[4] The Company expects that substantially all of the outstanding awards will vest in future periods.
[5] The 0.5 million RSUs granted consisted of 0.2 million performance-based RSUs awarded to executives and 0.3 million service-based RSUs awarded to non-executive employees and certain board members. The 0.2 million performance-based RSUs represents the target amount of the grant for the year, which is tied to an increase in the Company’s subscription-based research contract value (“CV”) for 2014. The final number of performance-based RSUs that will ultimately vest for 2014 ranges from 0% to 200% of the target amount, with the final number dependent on the actual increase in CV for 2014 as measured on December 31, 2014. If the specified minimum level of achievement is not met, the performance-based RSUs will be forfeited in their entirety, and any compensation expense previously recorded will be reversed.